[Impaired hematopoiesis through Thorium-x therapy].
D000750:Anemia, Myelophthisic / Q000139:chemically induced; D004920:Erythropoiesis / Q000528:radiation effects; D005500:Follow-Up Studies; D006410:Hematopoiesis / Q000528:radiation effects*; D006454:Hemoglobins / Q000528:radiation effects; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D007952:Leukemia, Plasma Cell / Q000139:chemically induced; D007953:Leukemia, Radiation-Induced; D007970:Leukopenia / Q000139:chemically induced; D009196:Myeloproliferative Disorders / Q000139:chemically induced*; D055728:Primary Myelofibrosis / Q000139:chemically induced; D011832:Radiation Injuries; D011878:Radiotherapy / Q000009:adverse effects; D013167:Spondylitis, Ankylosing / Q000532:radiotherapy; D013910:Thorium / Q000009:adverse effects* / Q000627:therapeutic use
D006454:Hemoglobins; D013910:Thorium
Schädigungen der Hämatopoese durch Thorium-X-Therapie.